![June Almenoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
June Almenoff
Director/Board Member at
TENAX THERAPEUTICS, INC.
Net worth: 90 121 $ as of 30/05/2026
Profile
June Sherie Almenoff is currently an Independent Director at Tenax Therapeutics, Inc. since 2021 and an Independent Director at Actinium Pharmaceuticals, Inc. since 2024.
Former positions include President, CEO, Director & Chief Medical Officer at Furiex Pharmaceuticals, Inc. from 2010 to 2014; Executive Chairman at RDD Pharma Ltd. from 2015 to 2018; Independent Non-Executive Director at TiGenix NV from 2016 to 2018; Director at Kurome Therapeutics, Inc. from 2020 to 2021; Independent Director at Ohr Pharmaceutical, Inc. from 2013 to 2019; Independent Director at Brainstorm Cell Therapeutics, Inc. from 2017 to 2023; Independent Director at Avalo Therapeutics, Inc. from 2021 to 2025; Vice President-Clinical Safety Organization at GlaxoSmithKline LLC from 1997 to 2010; Chief Operating & Medical Officer at 9 Meters Biopharma, Inc. in 2018; and Chief Medical Officer at RedHill Biopharma Ltd. Membership in the Infectious Diseases Society of America is noted.
Education includes undergraduate studies at Smith College and a doctorate from Icahn School of Medicine at Mount Sinai.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/06/2025 | 4,167 ( 0.01% ) | 66 464 $ | 30/05/2026 | |
| 07/04/2026 | 1,993 ( 0.01% ) | 23 657 $ | 30/05/2026 |
June Almenoff active positions
| Companies | Position | Start |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Director/Board Member | 24/02/2021 |
| ACTINIUM PHARMACEUTICALS, INC. | Director/Board Member | 31/10/2024 |
Former positions of June Almenoff
| Companies | Position | End |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Director/Board Member | 30/09/2025 |
| BRAINSTORM CELL THERAPEUTICS INC. | Director/Board Member | 30/11/2023 |
Kurome Therapeutics, Inc.
 Kurome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies that target cancer cells | Director/Board Member | 31/12/2020 |
Ohr Pharmaceutical, Inc.
 Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals for the treatment of serious and unmet medical needs | Director/Board Member | 11/07/2019 |
| 9 METERS BIOPHARMA, INC. | Chief Operating Officer | 15/11/2018 |
Training of June Almenoff
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
50
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Tenax Therapeutics, Inc.
 Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
TiGenix NV
 TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
Furiex Pharmaceuticals, Inc.
 Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development collaboration company | Health Technology |
Smith College
 Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services Operates as a medical association representing physicians, scientists, and other healthcare professionals | Commercial Services |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology Develops pharmacological treatments for diseases of the anorectal region | Health Technology |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals for the treatment of serious and unmet medical needs | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
RedHill Biopharma Ltd.
 RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Kurome Therapeutics, Inc.
Kurome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies that target cancer cells | Health Technology |
- Stock Market
- Insiders
- June Almenoff
